SPOTLIGHT: Deal or no deal for Lilly?

Remember the expert witness who leaked damaging documents about Zyprexa, Eli Lilly's schizophrenia med? He agreed to pay $100,000 to settle Lilly's lawsuit against him. But now the two are fighting over Lilly's' announcement of the deal because the company said he admitted breaking the law, but his lawyer says he admitted no such thing. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.